Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.

Pulvirenti F, Pentassuglio I, Milito C, Valente M, De Santis A, Conti V, d'Amati G, Riggio O, Quinti I.

J Immunol Res. 2014;2014:672458. doi: 10.1155/2014/672458. Epub 2014 Mar 31.

2.

Idiopathic portal hypertension complicated by ischemic hepatitis: the diagnostic importance of hemodynamics and liver biopsy.

Miranda-García P, López-Martín MC, Alvarez-Malé T, Casanova-González MJ, Santander C, Bañares R, Moreno-Otero R, Trapero-Marugán M.

Rev Esp Enferm Dig. 2012 Feb;104(1):45-7. English, Spanish. No abstract available.

PMID:
22300122
3.

Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly.

Okuda K, Kono K, Ohnishi K, Kimura K, Omata M, Koen H, Nakajima Y, Musha H, Hirashima T, Takashi M, et al.

Gastroenterology. 1984 Apr;86(4):600-10.

PMID:
6698361
4.

Unexpected disappearance of portal cavernoma on long-term anticoagulation.

Silva-Junior G, Turon F, Hernandez-Gea V, Darnell A, García-Criado Á, García-Pagán JC.

J Hepatol. 2014 Aug;61(2):446-8. doi: 10.1016/j.jhep.2014.04.002. Epub 2014 Apr 5.

PMID:
24713187
5.

 Idiopathic portal hypertension with multiple hepatic hyperplastic nodules supplied by portal vein.

Ikeda A, Kita R, Nasu A, Nishijima N, Matsuo H, Kimura T, Osaki Y, Ohbu M.

Ann Hepatol. 2012 Jul-Aug;11(4):572-3. No abstract available.

6.

Idiopathic portal hypertension associated with progressive systemic sclerosis.

Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T.

Am J Gastroenterol. 1982 Sep;77(9):645-8.

PMID:
7114027
7.

Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies.

Sato Y, Ren XS, Harada K, Sasaki M, Morikawa H, Shiomi S, Honda M, Kaneko S, Nakanuma Y.

Clin Exp Immunol. 2012 Mar;167(3):532-42. doi: 10.1111/j.1365-2249.2011.04530.x.

8.

 Hepatoportal sclerosis related to the use of herbals and nutritional supplements. Causality or coincidence?

Rios FF, Rodrigues de Freitas LA, Codes L, Santos Junior GO, Schinoni MI, Paraná R.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):932-938.

9.

Autoimmune polyglandular syndrome III in a patient with idiopathic portal hypertension.

Iwahashi A, Nakatani Y, Hirobata T, Nakata H, Funakoshi S, Yamashita Y, Inoue G.

Intern Med. 2013;52(12):1375-8.

10.

Role of endothelial-mesenchymal transition in idiopathic portal hypertension.

Sato Y, Nakanuma Y.

Histol Histopathol. 2013 Feb;28(2):145-54. doi: 10.14670/HH-28.145. Review.

PMID:
23275299
11.

Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly.

Nayak NC, Ramalingaswami V.

Arch Pathol. 1969 Apr;87(4):359-69. No abstract available.

PMID:
5766763
12.

Portal hypertension and iron depletion in patients with genetic hemochromatosis.

Fracanzani AL, Fargion S, Romano R, Conte D, Piperno A, D'Alba R, Mandelli C, Fraquelli M, Pacchetti S, Braga M, et al.

Hepatology. 1995 Oct;22(4 Pt 1):1127-31.

PMID:
7557861
13.

Clinical and immunological course in two patients with idiopathic portal hypertension.

Tokushige K, Tsuchiya N, Yamaguchi N, Taniai M, Hashimoto E, Yamauchi K, Hayashi N.

J Gastroenterol. 2002;37(12):1086-9. No abstract available.

PMID:
12522545
14.

Hepatoportal sclerosis in childhood: some presenting with cholestatic features (a re-evaluation of 12 children).

Yilmaz G, Sari S, Egritas O, Dalgic B, Akyol G.

Pediatr Dev Pathol. 2012 Mar-Apr;15(2):107-13. doi: 10.2350/11-04-1017-OA.1. Epub 2011 Dec 8.

PMID:
22150463
15.

Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement.

Merkel C, Gatta A, Arnaboldi L, Zuin R.

Clin Physiol. 1985 Dec;5(6):531-9.

PMID:
4092413
16.

Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.

Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S.

J Gastroenterol Hepatol. 2002 Jan;17(1):6-16. Review.

PMID:
11895549
18.

Structural aspects of the liver in patients with biliary disease and portal hypertension.

Weinbren K, Hadjis NS, Blumgart LH.

J Clin Pathol. 1985 Sep;38(9):1013-20.

19.

A case report of early idiopathic portal hypertension.

Nakanuma Y, Kouda W, Nakano T, Uneno K, Tachibana S, Araki I.

Pathol Res Pract. 2001;197(11):759-63; discussion 765-7.

PMID:
11770020
20.

Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.

Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, Verkarre V, Bechade D, Poynard T, Hermine O, Cellier C.

J Hepatol. 2008 Jan;48(1):74-82. Epub 2007 Oct 17.

PMID:
17998147

Supplemental Content

Support Center